All data are based on the daily closing price as of April 28, 2025
b

Boryung

003850.KO
5.90 USD
-0.03
-0.51%

Overview

Last close
5.90 usd
Market cap
495.62M usd
52 week high
10.04 usd
52 week low
5.24 usd
Target price
10.39 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.7257
Price/Book Value
0.9119
Enterprise Value
479.52M usd
EV/Revenue
0.6805
EV/EBITDA
6.0286

Key financials

Revenue TTM
704.67M usd
Gross Profit TTM
251.74M usd
EBITDA TTM
78.51M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
789.77M usd
Net debt
N/A usd

About

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
  • Symbol
    003850.KO
  • Exchange
    KO
  • Isin
    KR7003850005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Jay Kim
  • Headquarter
    Seoul
  • Web site
    https://www.boryung.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top